IMVT compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name

IMVTImmunovant, Inc.

Mkt capRevenueRevenue

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

IMVTImmunovant, Inc.

TNGXTango Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

IMVT

1 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 6 '26±9.0%▲+1.17%×0.13

May 20 '26±15.6%▲+35.26%×2.26

Feb 6 '26±13.5%▲+12.43%×0.92

Nov 10 '25±16.2%▲+0.09%×0.01

TNGX

0 of 4at or beyond implied

Reportimpliedrealized× implied

Aug 11 '26±11.4%▼−4.81%×0.42

May 14 '26±14.3%▼−2.51%×0.17

= impliedIMVT realized, solidTNGX realized, hatchedOne scale, both sides: full bar = 43%× = |realized| ÷ impliedSource: market data

Mar 5 '26

±42.5%

▲+36.28%

×0.85

Jan 8 '26±30.3%▼−6.23%×0.20

IMVTImmunovant, Inc.

29.16▲+2.64%

Mkt cap$5.9BRevenue—Revenue—

TNGXTango Therapeutics, Inc.

23.59▲+8.43%

Regular sessionNov 3 '26

Mkt cap$3.7BRevenue$54MQ3 FY25Revenue$42MFY24

Compare

Regular sessionNov 3 '26

IMVTImmunovant, Inc.

TNGXTango Therapeutics, Inc.

29.16▲+2.64%

Price

23.59▲+8.43%

$5.9B

Mkt cap

$3.7B

—

Revenue

$54MQ3 FY25

—

Revenue

$42MFY24

IMVT29.16▲+2.64%vsTNGX23.59▲+8.43%Regular sessionNov 3 '26